順勢療法討論區 Homeopathy Discuss!

 註冊 register
查看: 2624|回復: 0

Speaker ~ Dr KLAUS von AMMON

admin 發表於 2015-6-5 17:08:36 | 顯示全部樓層 |閱讀模式
DAY 1 – 5 June 2015 ( 930-1030 )
Homeopathy research – the state of play and the way forward
順勢療法的研究 -戲劇的局勢和前進的方向

Dr Klaus von Ammon ,
Switzerland. Contribution ofclinical observations to the discovery of mode of action of homeopathicmedicines

Senior officer in research, teaching & clinical  service, Institute of Complementary Medicine KIKOM, University of Bern
Klaus von Ammon completed his medical studies in  Hamburg, Marburg/Lahn, and Munich and is trained in neurosurgery. His main  research topics in homeopathy are in epidemiology (Swiss-PEK and CAMbrella)  and children with ADHD.
Klaus von Ammon分別在漢堡、馬爾堡/蘭、和慕尼黑完成他的醫學課程,並曾受神經外科的訓練。他的主要研究課題是順勢療法的流行病學(瑞士-PEK和CAMbrella),和患有過度活躍症及專注力不足的兒童
Research area
Fischer F, Lewith G, Witt CM, Linde K, von Ammon K,  Cardini F, Falkenberg T, Fønnebø V, Johannessen H, Reiter B, Uehleke B,  Weidenhammer W, Brinkhaus B.  [A  research roadmap for complementary and alternative medicine - what we need to  know by 2020]. Forsch Komplementmed. 2014;21(2):e1-16. doi:  10.1159/000360744. Epub 2014 Mar 24.
2020年我們需要知道的 --- 輔助和另類醫療的科研藍圖
The CAMbrella coordination action was funded within  the Framework Programme 7. Its aim is to provide a research roadmap for  clinical and epidemiological research for complementary and alternative  medicine (CAM) that is appropriate for the health needs of European citizens  and acceptable to their national research institutes and healthcare providers  in both public and private sectors. One major issue in the European research  agenda is the demographic change and its impact on health care. Our vision  for 2020 is that there is an evidence base that enables European citizens to  make informed decisions about CAM, both positive and negative. This roadmap  proposes a strategic research agenda for the field of CAM designed to address  future European health care challenges. This roadmap is based on the results  of CAMbrella’s several work packages, literature reviews and expert  discussions including a consensus meeting.
We first conducted a systematic literature review on  key issues in clinical and epidemiological research in CAM to identify the  general concepts, methods and the strengths and weaknesses of current CAM  research. These findings were discussed in a workshop (Castellaro, Italy,  September 7–9th 2011) with international CAM experts and strategic and  methodological recommendations were defined in order to improve the rigor and  relevance of CAM research. These recommendations provide the basis for the  research roadmap, which was subsequently discussed in a consensus conference  (Järna, Sweden, May 9–11th 2012) with all CAMbrella members and the CAMbrella  advisory board. The roadmap was revised after this discussion in CAMbrella  Work Package (WP) 7 and finally approved by CAMbrella’s scientific steering  committee on September 26th 2012.
我們首先在輔助和另類醫療(CAM)臨床和流行病學研究的關鍵問題上進行系統性的文獻審查,以確定目前CAM研究的基本概念、方法、長處和短處。這些研究會於工作坊(2011年9 月7-9日於意大利卡斯泰拉羅)內,由國際CAM專家作討論,然後制定出策略性和型式上的建議,以提高CAM研究的嚴謹性和相關性。這些建議,隨後會被放到由CAMbrella成員和CAMbrella顧問委員會組成的共識會議(2012年9至11月於瑞典耶納)上作為研究藍圖的討論基礎。該藍圖會於CAMbrella工作組7中被討論然後進行了修改,最後CAMbrella的科學指導委員會於2012年9月26日作審批。
Our main findings show that CAM is very heterogenous  in terms of definitions and legal regulations between the European countries.  In addition, citizens’ needs and attitudes towards CAM as well as the use and  provision of CAM differ significantly between countries. In terms of research  methodology, there was consensus that CAM researchers should make use of all  the commonly accepted scientific research methods and employ those with  utmost diligence combined in a mixed methods framework.
We propose 6 core areas of research that should be  investigated to achieve a robust knowledge base and to allow stakeholders to  make informed decisions. These are:
1.       Research into the prevalence of CAM in Europe: Reviews show that  we do not know enough about the circumstances in which CAM is used by  Europeans. To enable a common European strategic approach, a clear picture of  current use is of the utmost importance.
2.       Research into differences regarding citizens’ attitudes and needs  towards CAM: Citizens are the driver for CAM utilization. Their needs and  views on CAM are a key priority, and their interests must be investigated and  addressed in future CAM research.
3.       Research into safety of CAM: Safety is a key issue for European  citizens. CAM is considered safe, but reliable data is scarce although  urgently needed in order to assess the risk and cost-benefit ratio of CAM.
CAM安全性的研究:安全性是歐洲公民的一個關鍵問題。  CAM被認為是安全的,儘管有著迫切需要去評估CAM的風險和成本效益,可靠的數據仍然是稀缺的。
4.       Research into the comparative effectiveness of CAM: Everybody  needs to know in what situation CAM is a reasonable choice. Therefore, we  recommend a clear emphasis on concurrent evaluation of the overall  effectiveness of CAM as an additional or alternative treatment strategy in  real-world settings.
5.       Research into effects of context and meaning: The impact of  effects of context and meaning on the outcome of CAM treatments must be  investigated; it is likely that they are significant.
6.       Research into different models of CAM health care integration:  There are different models of CAM being integrated into conventional medicine  throughout Europe, each with their respective strengths and limitations.  These models should be described and concurrently evaluated; innovative  models of CAM provision in health care systems should be one focus for CAM  research.
We also  propose a methodological framework for CAM research. We consider that a  framework of mixed methodological approaches is likely to yield the most  useful information. In this model, all available research strategies  including comparative effectiveness research utilising quantitative and  qualitative methods should be considered to enable us to secure the greatest  density of knowledge possible.
Stakeholders,  such as citizens, patients and providers, should be involved in every stage  of developing the specific and relevant research questions, study design and  the assurance of real-world relevance for the research. Furthermore,  structural and sufficient financial support for research into CAM is needed  to strengthen CAM research capacity if we wish to understand why it remains  so popular within the EU.
In order to consider employing CAM as part of the  solution to the health care, health creation and self-care challenges we face  by 2020, it is vital to obtain a robust picture of CAM use and reliable  information about its cost, safety and effectiveness in real-world settings.  We need to consider the availability, accessibility and affordability of CAM.  We need to engage in research excellence and utilise comparative  effectiveness approaches and mixed methods to obtain this data. Our recommendations  are both strategic and methodological. They are presented for the  consideration of researchers and funders while being designed to answer the  important and implicit questions posed by EU citizens currently using CAM in  apparently increasing numbers.
We propose that the EU actively supports an EU-wide  strategic approach that facilitates the development of CAM research. This  could be achieved in the first instance through funding a European CAM  coordinating research office dedicated to foster systematic communication  between EU governments, public, charitable and industry funders as well as  researchers, citizens and other stakeholders.
The aim of this office would be to coordinate  research strategy developments and research funding opportunities, as well as  to document and disseminate international research activities in this field.  With the aim to develop sustainability as second step, a European Centre for  CAM should be established that takes over the monitoring and further  development of a coordinated research strategy for CAM, as well as it should  have funds that can be awarded to foster high quality and robust independent  research with a focus on citizens health needs and pan-European  collaboration.歐洲CAM協調研究辦公室的目的是協調研究策略發展、和籌募科研經費的機會,記錄和發佈在該領域的國際研究活動。而第二步,是開發可持續性,其目的在於應建立歐洲CAM醫療中心,接管CAM協調性研究策略的監測和進一步發展,它應該以公民的健康需求和泛歐洲合作為重點,被授予研發基金,以培育高品質和強大的自主研發。
We wish to establish a solid funding for CAM  research to adequately inform health care and health creation decision-making  throughout the EU. This centre would ensure that our vision of a common,  strategic and scientifically rigorous approach to CAM research becomes our  legacy and Europe’s reality. We are confident that our recommendations will  serve these essential goals for EU citizens.

您需要登錄後才可以回帖 登錄 | 註冊 register


小黑屋|手機版|Archiver|順勢療法討論區 Homeopathy Discuss!  

GMT+8, 2019-11-19 08:21 , Processed in 0.088492 second(s), 23 queries .

Powered by Discuz! X3.1

© 2001-2013 Comsenz Inc.

快速回復 返回頂部 返回列表